Endovascular Today20h
Fluidx Medical Begins Multinational Trial of GPX Embolic Device
Fluidx Medical Technology, Inc. announced that the first patient has been treated in the prospective, multinational, clinical ...
Endovascular Today2d
IceCure’s ProSense Cryoablation System’s Benefit-Risk Profile for Breast Cancer Indications Reviewed by FDA Panel
IceCure Medical Ltd. recently announced the FDA Medical Device Advisory Committee Panel’s favorable recommendation (voti ...
Endovascular Today1d
Bentley’s BeFlared Bridging Stent for FEVAR Used in First-in-Human Procedure
Bentley InnoMed GmbH announced the first-in-human implantation of the BeFlared stent graft system, which recently received CE ...
Endovascular Today3d
Boston Scientific to Acquire Intera Oncology
Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Intera Oncology Inc. Boston ...
Endovascular Today5d
Bentley’s BeGraft and BeFlared Gain TÜV Certification as Bridging Stents for FEVAR
Bentley InnoMed GmbH announced it has been granted two TÜV certificates that extend indications for its stents in complex ...
Endovascular Today3d
Merit’s Wrapsody Device Evaluated in WAVE Pivotal Trial’s Arteriovenous Graft Cohort
Merit Medical Systems, Inc. announced 6-month findings from the single-arm arteriovenous graft (AVG) cohort of the WAVE pivota ...
Endovascular Today7d
Solaris Endovascular, Inc. Launched in the United States
Solaris Endovascular, Inc. recently announced the formation of the company, which will develop solutions for dialysis access i ...
Endovascular Today8d
Xeltis Receives FDA Breakthrough Device Designation for aXess Vascular Access Conduit, Begins US Pivotal Trial
Xeltis recently announced that the FDA has granted Breakthrough Device designation for the company’s aXess vascular acce ...
Endovascular Today8d
Simcere’s Sanbexin Before Thrombectomy Studied to Improve Outcomes After AIS in TASTE-2
Simcere Pharmaceuticals Group Ltd. recently announced that findings from the TASTE-2 clinical study have shown that the admini ...
Endovascular Today8d
1-Year Data Presented From enVVeno’s VenoValve Pivotal Trial
November 20, 2024—enVVeno Medical Corporation announced 1-year data on all patients from SAVVE, the United States pivotal trial of the company&r ...
Endovascular Today4d
Radial Access for SFA Intervention Using the IN.PACT™ 018 Drug-Coated Balloon With the SpiderFX™ Filter Wire
Robert L. Minor Jr, MD Interventional Cardiologist and Endovascular Specialist Director of Endovascular Interventions Limb ...
Endovascular Today4d
The Next Game Changers for Radial Access in…
Opportunities to improve or optimize radial access for peripheral artery disease and embolization include additions and ...